Erlangen, Bayern Apr 16, 2026 (Issuewire.com) - Terra Nostra Corporate Finance Beratung GmbH is sending a strong signal for the future of medical technology. As part of a strategic share deal, the Frankfurt-based company has increased its stake in AB-CT – Advanced Breast-CT GmbH of Erlangen to 100%.
With this full acquisition, Terra Nostra secures the capital base for the next phase of growth: the large-scale expansion of the globally unique breast CT technology in international markets.
A World-Class Legacy: The Vision of Prof. Willi Kalender
AB-CT is backed by an impressive scientific and entrepreneurial history. Founded by the late Prof. Dr. Willi Kalender—the inventor of spiral computed tomography and a pioneer of modern radiology—the company has turned the vision of pain-free, high-precision diagnostics into reality.
The fact that AB-CT stands today on the threshold of the global market is also thanks to the long-standing commitment of the Kalender family, a family of entrepreneurs who are friends of the company, and a strategic sales partner, all of whom have significantly supported the company’s development to this day.
Scientific Excellence: The nu:view Breast CT
The flagship product nu:view is the world’s first breast CT system based on direct photon-counting detectors. The technology offers significant clinical and patient-centred benefits:
- Highest diagnostic accuracy: Thanks to an isotropic spatial resolution of up to 90 µm, even the smallest microcalcifications are displayed precisely and without overlap.
- Completely pain-free: Unlike mammography, the examination is performed without any compression of the breast.
- Maximum speed: A complete scan takes only 7 to 12 seconds per breast.
- Maximum comfort: The patient lies relaxed in a prone position, which minimizes the psychological stress of the examination.
- Low radiation dose: Thanks to the highly efficient detectors, radiation exposure is at the level of conventional digital mammography.
The technology has already proven itself internationally: In addition to leading clinics in Europe, nu:view systems are already being used successfully in Korea, China, and Australia.
Dr. Daniel J. Novacek Takes the Helm Dr. Daniel J. Novacek, LL.M., has been appointed as the new CEO and, thru his family office, became a co-shareholder to lead this ambitious phase. Dr. Novacek possesses in-depth expertise in diagnostic imaging as well as extensive experience in business development and revenue growth within the MedTech sector. Throughout his career, he already has been responsible for global operations for international diagnostics companies.
Statement from Dr. Daniel J. Novacek:
“With nu:view, AB-CT possesses a disruptive technology that fundamentally improve breast diagnostics for women worldwide. Our goal is to translate the excellent scientific work of Prof. Kalender and his team into a broad international market presence. We will strengthen the existing structures in Erlangen and expand our already successful activities in the DACH region, Benelux, Asia, and Australia, as well as tap into new global markets to establish nu:view as gold standard in diagnostic protocols.”
About Terra Nostra Corporate Finance Beratung GmbH
Terra Nostra is a specialized investor based in Frankfurt am Main that consistently promotes innovation. In addition to its focus on high-tech medical technology, the company is also active in conventional industries such as logistics, road construction, finance, and other sectors. Terra Nostra’s goal is to transform technological excellence and operational strength into sustainable economic success.
About AB-CT GmbH
AB-CT – Advanced Breast-CT GmbH, based in Erlangen, is a leading innovator in radiological imaging. The company develops, manufactures and markets high-end systems for specialized diagnostic imaging to improve the early detection of neoplasms, such as breast cancer, through technological advancement and maximum patient comfort.
Media Contact
AB-CT GmbH Mrs. Adriana Kalender adriana.kalender@ab-ct.com http://ab-ct.com
